GILD Message Board Post 8924956 | Gilead Sciences Inc.
home / stock / gild / gild message board
thas
(investorshub)
Posted on: Mar/21/2023 20:18:16
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171502966
Kite just released ZUMA-7 results for 2L https://www.businesswire.com/news/home/
News, Short Squeeze, Breakout and More Instantly...
-
– Analysis Comparing Real-World and Clinical Trial Data Show Yescarta ® Has Higher Manufacturing Success Rates and Improved T-Cell Performance, Respectively, in Second-Line vs. Third-Line+ Treatment of Large B-cell Lymphoma – – Encore Oral Present...
-
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMiD) drug and an anti-CD38 monoclonal antibody -- -- Anito-cel will be manufactured from Kite’s Frederick, Maryland facility for iMMagine-3 as th...
-
NORTHAMPTON, MA / ACCESSWIRE / May 9, 2024 / A 22-year-old college student who didn't feel well was treated at an urgent care facility in Baton Rouge, Louisiana and expected to recover soon. But when his symptoms worsened, he returned to the emergency department and was given a more thorough che...